Abbott shares weekly forecast: Rebound odds stay low with RSI nearing oversold territory

Traders Union
All News
Stocks
Abbott Laboratories slips 0.62% this week

Highlights

Shares of Abbott closed at $100.75 and sit below key moving averages, indicating a weak technical structure.
Bearish momentum dominates as shares test the lower weekly range and exhibit signals near oversold territory.
The expected range for the week ahead is $98.21 to $102.7 with a high probability of continued downside.

Digital health expansion and clinical updates offset by lingering competitive concerns

Abbott announced an exclusive partnership with Berry Street to pair its Lingo continuous glucose monitor with insurance-covered virtual nutrition coaching, according to StockTitan.net and finance.yahoo.com, highlighting moves to expand its digital health offerings. Clinical milestones were also reached as the company's Volt Pulsed Field Ablation System was used for the first time in Canada and at UnityPoint Health in Illinois, simplywall.st and finance.yahoo.com reported. Meanwhile, SEC filings showed that director Kevin T. Conroy disposed of 52,507 shares for tax withholding, a routine event, and Tributary Capital Management flagged continued competitive challenges and slow recovery in the nutrition business, as noted by Yahoo Finance.

Bearish technical momentum persists as price tests weekly support levels

On the daily chart, the structure is bearish as price remains well below the key moving averages and continues to test the lower end of its weekly range, with volatility for the past week at 4.36%. Momentum signals reinforce this: RSI stands at 36.09 and is approaching oversold, while MACD remains in a clear sell direction. The nearest support sits at $100.16 and resistance stands at $104.53, while the Ichimoku Kijun offers further resistance at $108.69. This combination points to an emerging move lower that is not yet confirmed.

Sideways-to-lower bias dominates as downside breakout risk rises next week

In the week ahead, the expected range is $98.21 to $102.7. There is a very low probability of an increase (less than 20%) and a very high probability of a decrease (more than 80%). The base case is continued sideways-to-lower movement inside the range, with price drifting between support at $100.16 and resistance at $104.53. A bullish scenario would require a sustained move above $104.53, while a break below $100.16 opens the door to downside towards $98.21.

Jainam Mehta, market strategist, observes that shares of Abbott Laboratories are consolidating near $101 after another muted week, with sellers maintaining consistent pressure. He notes that despite fresh corporate developments — such as the Lingo partnership in digital health and clinical advances with Volt Pulsed Field Ablation — technical momentum continues to signal weakness as price remains under daily moving averages. Mehta sees oversold conditions emerging, with RSI at 36.09, but support at $100.16 is yet to be convincingly tested, and the base case remains a sideways-to-lower drift inside $98.21–$102.7. "Oversold signals could spark a short-term pause, but unless shares sustain above $104.53, I stay positioned for more downside in the coming week."

Earlier, analysts noted that Abbott Laboratories was experiencing sustained downward momentum due to persistent competitive pressures and technical weakness. This outlook remains intact as recent developments and continued bearish price structure suggest that traders should closely monitor the $100.16 support level for emerging downside risk in the near term.

Source of Data: ABT Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.